TickerFactsScreenerDevelopers

SELLAS Life Sciences Group, Inc. (SLS) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $7.48M2011: $30.97M2012: $54.99M2013: $87.98M2014: $80.49M2015: $82.14M2016: $6.42M2017: $33.53M2018: $16.91M2019: $16.61M2020: $46.05M2021: $26.27M2022: $20.94M2023: $6.22M2024: $19.43M2025: $78.34M$78.34M
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$78.34M+303.2%
2024$19.43M+212.5%
2023$6.22M-70.3%
2022$20.94M-20.3%
2021$26.27M-42.9%
2020$46.05M+177.3%
2019$16.61M-1.8%
2018$16.91M-49.5%
2017$33.53M+422.2%
2016$6.42M-92.2%
2015$82.14M+2.1%
2014$80.49M-8.5%
2013$87.98M+60.0%
2012$54.99M+77.6%
2011$30.97M+314.2%
2010$7.48M—